nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—coronary artery disease—atherosclerosis	0.5	1	CtDrD
Lisinopril—ACE—atherosclerosis	0.243	1	CbGaD
Lisinopril—ABCB1—Ezetimibe—atherosclerosis	0.0217	0.267	CbGbCtD
Lisinopril—ABCB1—Simvastatin—atherosclerosis	0.0202	0.248	CbGbCtD
Lisinopril—ABCB1—Pravastatin—atherosclerosis	0.0198	0.243	CbGbCtD
Lisinopril—ABCB1—Lovastatin—atherosclerosis	0.0198	0.243	CbGbCtD
Lisinopril—ACE—thoracic aorta—atherosclerosis	0.00861	0.19	CbGeAlD
Lisinopril—ACE—renal artery—atherosclerosis	0.00699	0.154	CbGeAlD
Lisinopril—ACE—arteriole—atherosclerosis	0.00561	0.124	CbGeAlD
Lisinopril—ACE—tunica intima—atherosclerosis	0.00398	0.0881	CbGeAlD
Lisinopril—ACE—vein—atherosclerosis	0.00335	0.074	CbGeAlD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—ACE—atherosclerosis	0.00263	0.0809	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—ACE—atherosclerosis	0.0025	0.077	CbGpPWpGaD
Lisinopril—ACE—umbilical vein—atherosclerosis	0.00243	0.0537	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—KNG1—atherosclerosis	0.00227	0.0698	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—AGTR1—atherosclerosis	0.00226	0.0694	CbGpPWpGaD
Lisinopril—ACE—hindlimb—atherosclerosis	0.00222	0.0492	CbGeAlD
Lisinopril—ACE—appendage—atherosclerosis	0.00191	0.0422	CbGeAlD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—AGT—atherosclerosis	0.00167	0.0513	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—AGT—atherosclerosis	0.00159	0.0488	CbGpPWpGaD
Lisinopril—ACE2—cardiovascular system—atherosclerosis	0.00145	0.032	CbGeAlD
Lisinopril—ACE—artery—atherosclerosis	0.00136	0.0301	CbGeAlD
Lisinopril—ACE2—adipose tissue—atherosclerosis	0.00128	0.0283	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—PLA2G7—atherosclerosis	0.00122	0.0376	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—NOS3—atherosclerosis	0.00117	0.0359	CbGpPWpGaD
Lisinopril—ACE—endothelium—atherosclerosis	0.00115	0.0255	CbGeAlD
Lisinopril—ACE—blood vessel—atherosclerosis	0.00106	0.0235	CbGeAlD
Lisinopril—ACE—ACE Inhibitor Pathway—KNG1—atherosclerosis	0.00101	0.0312	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—AGTR1—atherosclerosis	0.00101	0.031	CbGpPWpGaD
Lisinopril—ACE2—liver—atherosclerosis	0.000896	0.0198	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—TGFB1—atherosclerosis	0.000771	0.0237	CbGpPWpGaD
Lisinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—atherosclerosis	0.000745	0.0229	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—GHRL—atherosclerosis	0.000714	0.022	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—AGT—atherosclerosis	0.000709	0.0218	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—ACE—atherosclerosis	0.000691	0.0213	CbGpPWpGaD
Lisinopril—Aspartame—TRPV1—atherosclerosis	0.00057	0.196	CrCbGaD
Lisinopril—ACE—Peptide hormone metabolism—PLA2G7—atherosclerosis	0.000546	0.0168	CbGpPWpGaD
Lisinopril—ACE—connective tissue—atherosclerosis	0.000544	0.012	CbGeAlD
Lisinopril—ACE—ACE Inhibitor Pathway—NOS3—atherosclerosis	0.000521	0.016	CbGpPWpGaD
Lisinopril—ACE—cardiovascular system—atherosclerosis	0.000474	0.0105	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—AGT—atherosclerosis	0.000438	0.0135	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—LEP—atherosclerosis	0.000429	0.0132	CbGpPWpGaD
Lisinopril—ACE—adipose tissue—atherosclerosis	0.000418	0.00924	CbGeAlD
Lisinopril—SLC15A1—liver—atherosclerosis	0.000409	0.00903	CbGeAlD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.000401	0.0123	CbGpPWpGaD
Lisinopril—ABCB1—blood vessel—atherosclerosis	0.000374	0.00826	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—INS—atherosclerosis	0.000367	0.0113	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—IGF1—atherosclerosis	0.000355	0.0109	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—TGFB1—atherosclerosis	0.000344	0.0106	CbGpPWpGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—ABCG4—atherosclerosis	0.00032	0.00984	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—GHRL—atherosclerosis	0.000319	0.00981	CbGpPWpGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—ABCG8—atherosclerosis	0.000307	0.00943	CbGpPWpGaD
Lisinopril—Fosinopril—ACE—atherosclerosis	0.000297	0.102	CrCbGaD
Lisinopril—ACE—liver—atherosclerosis	0.000293	0.00648	CbGeAlD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000254	0.00781	CbGpPWpGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—ABCG1—atherosclerosis	0.000242	0.00746	CbGpPWpGaD
Lisinopril—Spirapril—ACE—atherosclerosis	0.000239	0.0824	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—PLA2G7—atherosclerosis	0.000231	0.0071	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.00023	0.00708	CbGpPWpGaD
Lisinopril—Moexipril—ACE—atherosclerosis	0.000229	0.079	CrCbGaD
Lisinopril—Benazepril—MTHFR—atherosclerosis	0.000228	0.0784	CrCbGaD
Lisinopril—Quinapril—ACE—atherosclerosis	0.000213	0.0734	CrCbGaD
Lisinopril—Cilazapril—ACE—atherosclerosis	0.000213	0.0734	CrCbGaD
Lisinopril—Ramipril—ACE—atherosclerosis	0.000206	0.0711	CrCbGaD
Lisinopril—Trandolapril—ACE—atherosclerosis	0.000206	0.0711	CrCbGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000199	0.00613	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—AGT—atherosclerosis	0.000196	0.00602	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—LEP—atherosclerosis	0.000192	0.0059	CbGpPWpGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—ABCG5—atherosclerosis	0.00019	0.00585	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—HSPD1—atherosclerosis	0.000188	0.00577	CbGpPWpGaD
Lisinopril—Benazepril—ACE—atherosclerosis	0.000185	0.0639	CrCbGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—atherosclerosis	0.000169	0.00519	CbGpPWpGaD
Lisinopril—ABCB1—cardiovascular system—atherosclerosis	0.000167	0.00369	CbGeAlD
Lisinopril—ACE—Peptide hormone metabolism—INS—atherosclerosis	0.000164	0.00504	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—IGF1—atherosclerosis	0.000158	0.00487	CbGpPWpGaD
Lisinopril—Enalapril—ACE—atherosclerosis	0.000156	0.0539	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—F7—atherosclerosis	0.000151	0.00465	CbGpPWpGaD
Lisinopril—ABCB1—adipose tissue—atherosclerosis	0.000147	0.00325	CbGeAlD
Lisinopril—Tinnitus—Pravastatin—atherosclerosis	0.000138	0.00146	CcSEcCtD
Lisinopril—Malaise—Lovastatin—atherosclerosis	0.000138	0.00146	CcSEcCtD
Lisinopril—Flushing—Pravastatin—atherosclerosis	0.000138	0.00146	CcSEcCtD
Lisinopril—Muscle spasms—Simvastatin—atherosclerosis	0.000137	0.00145	CcSEcCtD
Lisinopril—Vertigo—Lovastatin—atherosclerosis	0.000137	0.00145	CcSEcCtD
Lisinopril—Angioedema—Ezetimibe—atherosclerosis	0.000137	0.00145	CcSEcCtD
Lisinopril—Angiopathy—Niacin—atherosclerosis	0.000137	0.00145	CcSEcCtD
Lisinopril—Leukopenia—Lovastatin—atherosclerosis	0.000137	0.00145	CcSEcCtD
Lisinopril—Chills—Niacin—atherosclerosis	0.000135	0.00143	CcSEcCtD
Lisinopril—Malaise—Ezetimibe—atherosclerosis	0.000135	0.00143	CcSEcCtD
Lisinopril—Vision blurred—Simvastatin—atherosclerosis	0.000135	0.00142	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—GHRL—atherosclerosis	0.000135	0.00414	CbGpPWpGaD
Lisinopril—Arrhythmia—Niacin—atherosclerosis	0.000135	0.00142	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000134	0.00142	CcSEcCtD
Lisinopril—Tremor—Simvastatin—atherosclerosis	0.000134	0.00142	CcSEcCtD
Lisinopril—Alopecia—Niacin—atherosclerosis	0.000133	0.00141	CcSEcCtD
Lisinopril—Chills—Pravastatin—atherosclerosis	0.000133	0.00141	CcSEcCtD
Lisinopril—Insomnia—Rosuvastatin—atherosclerosis	0.000133	0.00141	CcSEcCtD
Lisinopril—Ill-defined disorder—Simvastatin—atherosclerosis	0.000133	0.0014	CcSEcCtD
Lisinopril—Arrhythmia—Pravastatin—atherosclerosis	0.000133	0.0014	CcSEcCtD
Lisinopril—Palpitations—Ezetimibe—atherosclerosis	0.000132	0.0014	CcSEcCtD
Lisinopril—Paraesthesia—Rosuvastatin—atherosclerosis	0.000132	0.0014	CcSEcCtD
Lisinopril—Anaemia—Simvastatin—atherosclerosis	0.000132	0.0014	CcSEcCtD
Lisinopril—Malnutrition—Niacin—atherosclerosis	0.000131	0.00139	CcSEcCtD
Lisinopril—Erythema—Niacin—atherosclerosis	0.000131	0.00139	CcSEcCtD
Lisinopril—Alopecia—Pravastatin—atherosclerosis	0.000131	0.00139	CcSEcCtD
Lisinopril—Cough—Ezetimibe—atherosclerosis	0.000131	0.00138	CcSEcCtD
Lisinopril—Angioedema—Simvastatin—atherosclerosis	0.000131	0.00138	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—ACE—atherosclerosis	0.00013	0.00401	CbGpPWpGaD
Lisinopril—Arthralgia—Lovastatin—atherosclerosis	0.00013	0.00137	CcSEcCtD
Lisinopril—Myalgia—Lovastatin—atherosclerosis	0.00013	0.00137	CcSEcCtD
Lisinopril—Chest pain—Lovastatin—atherosclerosis	0.00013	0.00137	CcSEcCtD
Lisinopril—Anxiety—Lovastatin—atherosclerosis	0.00013	0.00137	CcSEcCtD
Lisinopril—Dyspepsia—Rosuvastatin—atherosclerosis	0.00013	0.00137	CcSEcCtD
Lisinopril—Flatulence—Niacin—atherosclerosis	0.000129	0.00137	CcSEcCtD
Lisinopril—Malaise—Simvastatin—atherosclerosis	0.000129	0.00136	CcSEcCtD
Lisinopril—Tension—Niacin—atherosclerosis	0.000129	0.00136	CcSEcCtD
Lisinopril—Discomfort—Lovastatin—atherosclerosis	0.000129	0.00136	CcSEcCtD
Lisinopril—Vertigo—Simvastatin—atherosclerosis	0.000128	0.00136	CcSEcCtD
Lisinopril—Leukopenia—Simvastatin—atherosclerosis	0.000128	0.00135	CcSEcCtD
Lisinopril—Myalgia—Ezetimibe—atherosclerosis	0.000128	0.00135	CcSEcCtD
Lisinopril—Chest pain—Ezetimibe—atherosclerosis	0.000128	0.00135	CcSEcCtD
Lisinopril—Arthralgia—Ezetimibe—atherosclerosis	0.000128	0.00135	CcSEcCtD
Lisinopril—Nervousness—Niacin—atherosclerosis	0.000128	0.00135	CcSEcCtD
Lisinopril—Flatulence—Pravastatin—atherosclerosis	0.000127	0.00135	CcSEcCtD
Lisinopril—Dry mouth—Lovastatin—atherosclerosis	0.000127	0.00134	CcSEcCtD
Lisinopril—Tension—Pravastatin—atherosclerosis	0.000127	0.00134	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000127	0.00134	CcSEcCtD
Lisinopril—Dysgeusia—Pravastatin—atherosclerosis	0.000127	0.00134	CcSEcCtD
Lisinopril—Muscle spasms—Niacin—atherosclerosis	0.000126	0.00133	CcSEcCtD
Lisinopril—Discomfort—Ezetimibe—atherosclerosis	0.000126	0.00133	CcSEcCtD
Lisinopril—Pain—Rosuvastatin—atherosclerosis	0.000126	0.00133	CcSEcCtD
Lisinopril—Constipation—Rosuvastatin—atherosclerosis	0.000126	0.00133	CcSEcCtD
Lisinopril—Confusional state—Lovastatin—atherosclerosis	0.000126	0.00133	CcSEcCtD
Lisinopril—Nervousness—Pravastatin—atherosclerosis	0.000126	0.00133	CcSEcCtD
Lisinopril—Dry mouth—Ezetimibe—atherosclerosis	0.000125	0.00132	CcSEcCtD
Lisinopril—Anaphylactic shock—Lovastatin—atherosclerosis	0.000125	0.00132	CcSEcCtD
Lisinopril—Muscle spasms—Pravastatin—atherosclerosis	0.000124	0.00131	CcSEcCtD
Lisinopril—Infection—Lovastatin—atherosclerosis	0.000124	0.00131	CcSEcCtD
Lisinopril—Vision blurred—Niacin—atherosclerosis	0.000124	0.00131	CcSEcCtD
Lisinopril—Confusional state—Ezetimibe—atherosclerosis	0.000123	0.0013	CcSEcCtD
Lisinopril—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000122	0.00129	CcSEcCtD
Lisinopril—Thrombocytopenia—Lovastatin—atherosclerosis	0.000122	0.00129	CcSEcCtD
Lisinopril—Vision blurred—Pravastatin—atherosclerosis	0.000122	0.00129	CcSEcCtD
Lisinopril—Myalgia—Simvastatin—atherosclerosis	0.000122	0.00129	CcSEcCtD
Lisinopril—Chest pain—Simvastatin—atherosclerosis	0.000122	0.00129	CcSEcCtD
Lisinopril—Arthralgia—Simvastatin—atherosclerosis	0.000122	0.00129	CcSEcCtD
Lisinopril—Infection—Ezetimibe—atherosclerosis	0.000122	0.00128	CcSEcCtD
Lisinopril—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000121	0.00128	CcSEcCtD
Lisinopril—Anxiety—Simvastatin—atherosclerosis	0.000121	0.00128	CcSEcCtD
Lisinopril—Tremor—Pravastatin—atherosclerosis	0.000121	0.00128	CcSEcCtD
Lisinopril—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00012	0.00127	CcSEcCtD
Lisinopril—Discomfort—Simvastatin—atherosclerosis	0.00012	0.00127	CcSEcCtD
Lisinopril—Angioedema—Niacin—atherosclerosis	0.00012	0.00127	CcSEcCtD
Lisinopril—Ill-defined disorder—Pravastatin—atherosclerosis	0.00012	0.00127	CcSEcCtD
Lisinopril—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00012	0.00127	CcSEcCtD
Lisinopril—Anaemia—Pravastatin—atherosclerosis	0.000119	0.00126	CcSEcCtD
Lisinopril—Anorexia—Lovastatin—atherosclerosis	0.000119	0.00126	CcSEcCtD
Lisinopril—Skin disorder—Ezetimibe—atherosclerosis	0.000119	0.00126	CcSEcCtD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000119	0.00366	CbGpPWpGaD
Lisinopril—Angioedema—Pravastatin—atherosclerosis	0.000118	0.00125	CcSEcCtD
Lisinopril—Vertigo—Niacin—atherosclerosis	0.000118	0.00125	CcSEcCtD
Lisinopril—Syncope—Niacin—atherosclerosis	0.000118	0.00124	CcSEcCtD
Lisinopril—Confusional state—Simvastatin—atherosclerosis	0.000118	0.00124	CcSEcCtD
Lisinopril—Leukopenia—Niacin—atherosclerosis	0.000118	0.00124	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—PLAUR—atherosclerosis	0.000117	0.00361	CbGpPWpGaD
Lisinopril—Urticaria—Rosuvastatin—atherosclerosis	0.000117	0.00124	CcSEcCtD
Lisinopril—Oedema—Simvastatin—atherosclerosis	0.000117	0.00123	CcSEcCtD
Lisinopril—Anaphylactic shock—Simvastatin—atherosclerosis	0.000117	0.00123	CcSEcCtD
Lisinopril—Malaise—Pravastatin—atherosclerosis	0.000117	0.00123	CcSEcCtD
Lisinopril—Nateglinide—PPARG—atherosclerosis	0.000116	0.0401	CrCbGaD
Lisinopril—Abdominal pain—Rosuvastatin—atherosclerosis	0.000116	0.00123	CcSEcCtD
Lisinopril—Vertigo—Pravastatin—atherosclerosis	0.000116	0.00123	CcSEcCtD
Lisinopril—Palpitations—Niacin—atherosclerosis	0.000116	0.00123	CcSEcCtD
Lisinopril—Infection—Simvastatin—atherosclerosis	0.000116	0.00122	CcSEcCtD
Lisinopril—Leukopenia—Pravastatin—atherosclerosis	0.000116	0.00122	CcSEcCtD
Lisinopril—Loss of consciousness—Niacin—atherosclerosis	0.000115	0.00122	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—PLG—atherosclerosis	0.000115	0.00352	CbGpPWpGaD
Lisinopril—Cough—Niacin—atherosclerosis	0.000115	0.00121	CcSEcCtD
Lisinopril—Thrombocytopenia—Simvastatin—atherosclerosis	0.000114	0.00121	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000114	0.0012	CcSEcCtD
Lisinopril—Insomnia—Lovastatin—atherosclerosis	0.000113	0.00119	CcSEcCtD
Lisinopril—Cough—Pravastatin—atherosclerosis	0.000113	0.00119	CcSEcCtD
Lisinopril—Paraesthesia—Lovastatin—atherosclerosis	0.000112	0.00118	CcSEcCtD
Lisinopril—Arthralgia—Niacin—atherosclerosis	0.000112	0.00118	CcSEcCtD
Lisinopril—Myalgia—Niacin—atherosclerosis	0.000112	0.00118	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000111	0.00118	CcSEcCtD
Lisinopril—Anorexia—Simvastatin—atherosclerosis	0.000111	0.00118	CcSEcCtD
Lisinopril—Dyspnoea—Lovastatin—atherosclerosis	0.000111	0.00117	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000111	0.00117	CcSEcCtD
Lisinopril—Insomnia—Ezetimibe—atherosclerosis	0.000111	0.00117	CcSEcCtD
Lisinopril—Chest pain—Pravastatin—atherosclerosis	0.00011	0.00116	CcSEcCtD
Lisinopril—Arthralgia—Pravastatin—atherosclerosis	0.00011	0.00116	CcSEcCtD
Lisinopril—Myalgia—Pravastatin—atherosclerosis	0.00011	0.00116	CcSEcCtD
Lisinopril—Paraesthesia—Ezetimibe—atherosclerosis	0.00011	0.00116	CcSEcCtD
Lisinopril—Dyspepsia—Lovastatin—atherosclerosis	0.00011	0.00116	CcSEcCtD
Lisinopril—Anxiety—Pravastatin—atherosclerosis	0.00011	0.00116	CcSEcCtD
Lisinopril—Dry mouth—Niacin—atherosclerosis	0.000109	0.00115	CcSEcCtD
Lisinopril—Dyspnoea—Ezetimibe—atherosclerosis	0.000109	0.00115	CcSEcCtD
Lisinopril—Discomfort—Pravastatin—atherosclerosis	0.000109	0.00115	CcSEcCtD
Lisinopril—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000108	0.00115	CcSEcCtD
Lisinopril—Decreased appetite—Lovastatin—atherosclerosis	0.000108	0.00115	CcSEcCtD
Lisinopril—Dyspepsia—Ezetimibe—atherosclerosis	0.000108	0.00114	CcSEcCtD
Lisinopril—Fatigue—Lovastatin—atherosclerosis	0.000108	0.00114	CcSEcCtD
Lisinopril—Anaphylactic shock—Niacin—atherosclerosis	0.000107	0.00113	CcSEcCtD
Lisinopril—Oedema—Niacin—atherosclerosis	0.000107	0.00113	CcSEcCtD
Lisinopril—Constipation—Lovastatin—atherosclerosis	0.000107	0.00113	CcSEcCtD
Lisinopril—Pain—Lovastatin—atherosclerosis	0.000107	0.00113	CcSEcCtD
Lisinopril—Confusional state—Pravastatin—atherosclerosis	0.000106	0.00112	CcSEcCtD
Lisinopril—Decreased appetite—Ezetimibe—atherosclerosis	0.000106	0.00112	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000106	0.00112	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000106	0.00112	CcSEcCtD
Lisinopril—Asthenia—Rosuvastatin—atherosclerosis	0.000106	0.00112	CcSEcCtD
Lisinopril—Insomnia—Simvastatin—atherosclerosis	0.000106	0.00111	CcSEcCtD
Lisinopril—Oedema—Pravastatin—atherosclerosis	0.000105	0.00111	CcSEcCtD
Lisinopril—Anaphylactic shock—Pravastatin—atherosclerosis	0.000105	0.00111	CcSEcCtD
Lisinopril—Fatigue—Ezetimibe—atherosclerosis	0.000105	0.00111	CcSEcCtD
Lisinopril—Shock—Niacin—atherosclerosis	0.000105	0.00111	CcSEcCtD
Lisinopril—Infection—Pravastatin—atherosclerosis	0.000105	0.00111	CcSEcCtD
Lisinopril—Paraesthesia—Simvastatin—atherosclerosis	0.000105	0.00111	CcSEcCtD
Lisinopril—Constipation—Ezetimibe—atherosclerosis	0.000105	0.00111	CcSEcCtD
Lisinopril—Pain—Ezetimibe—atherosclerosis	0.000105	0.00111	CcSEcCtD
Lisinopril—Tachycardia—Niacin—atherosclerosis	0.000105	0.0011	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—IGF2—atherosclerosis	0.000104	0.00321	CbGpPWpGaD
Lisinopril—Pruritus—Rosuvastatin—atherosclerosis	0.000104	0.0011	CcSEcCtD
Lisinopril—Skin disorder—Niacin—atherosclerosis	0.000104	0.0011	CcSEcCtD
Lisinopril—Dyspnoea—Simvastatin—atherosclerosis	0.000104	0.0011	CcSEcCtD
Lisinopril—Hyperhidrosis—Niacin—atherosclerosis	0.000104	0.00109	CcSEcCtD
Lisinopril—Thrombocytopenia—Pravastatin—atherosclerosis	0.000103	0.00109	CcSEcCtD
Lisinopril—ABCB1—liver—atherosclerosis	0.000103	0.00228	CbGeAlD
Lisinopril—ACE—Metabolism of proteins—PLA2G7—atherosclerosis	0.000103	0.00317	CbGpPWpGaD
Lisinopril—Feeling abnormal—Lovastatin—atherosclerosis	0.000103	0.00109	CcSEcCtD
Lisinopril—Dyspepsia—Simvastatin—atherosclerosis	0.000103	0.00109	CcSEcCtD
Lisinopril—Anorexia—Niacin—atherosclerosis	0.000102	0.00108	CcSEcCtD
Lisinopril—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000102	0.00108	CcSEcCtD
Lisinopril—Hyperhidrosis—Pravastatin—atherosclerosis	0.000102	0.00108	CcSEcCtD
Lisinopril—Decreased appetite—Simvastatin—atherosclerosis	0.000101	0.00107	CcSEcCtD
Lisinopril—Feeling abnormal—Ezetimibe—atherosclerosis	0.000101	0.00107	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000101	0.00106	CcSEcCtD
Lisinopril—Diarrhoea—Rosuvastatin—atherosclerosis	0.000101	0.00106	CcSEcCtD
Lisinopril—Fatigue—Simvastatin—atherosclerosis	0.000101	0.00106	CcSEcCtD
Lisinopril—Anorexia—Pravastatin—atherosclerosis	0.000101	0.00106	CcSEcCtD
Lisinopril—Hypotension—Niacin—atherosclerosis	0.0001	0.00106	CcSEcCtD
Lisinopril—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.0001	0.00106	CcSEcCtD
Lisinopril—Pain—Simvastatin—atherosclerosis	9.98e-05	0.00105	CcSEcCtD
Lisinopril—Constipation—Simvastatin—atherosclerosis	9.98e-05	0.00105	CcSEcCtD
Lisinopril—Urticaria—Lovastatin—atherosclerosis	9.91e-05	0.00105	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	9.89e-05	0.00304	CbGpPWpGaD
Lisinopril—Abdominal pain—Lovastatin—atherosclerosis	9.86e-05	0.00104	CcSEcCtD
Lisinopril—Body temperature increased—Lovastatin—atherosclerosis	9.86e-05	0.00104	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Niacin—atherosclerosis	9.76e-05	0.00103	CcSEcCtD
Lisinopril—Dizziness—Rosuvastatin—atherosclerosis	9.73e-05	0.00103	CcSEcCtD
Lisinopril—Urticaria—Ezetimibe—atherosclerosis	9.72e-05	0.00103	CcSEcCtD
Lisinopril—Insomnia—Niacin—atherosclerosis	9.69e-05	0.00102	CcSEcCtD
Lisinopril—Body temperature increased—Ezetimibe—atherosclerosis	9.67e-05	0.00102	CcSEcCtD
Lisinopril—Abdominal pain—Ezetimibe—atherosclerosis	9.67e-05	0.00102	CcSEcCtD
Lisinopril—Paraesthesia—Niacin—atherosclerosis	9.62e-05	0.00102	CcSEcCtD
Lisinopril—Feeling abnormal—Simvastatin—atherosclerosis	9.62e-05	0.00102	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Pravastatin—atherosclerosis	9.61e-05	0.00102	CcSEcCtD
Lisinopril—Dyspnoea—Niacin—atherosclerosis	9.55e-05	0.00101	CcSEcCtD
Lisinopril—Gastrointestinal pain—Simvastatin—atherosclerosis	9.54e-05	0.00101	CcSEcCtD
Lisinopril—Insomnia—Pravastatin—atherosclerosis	9.54e-05	0.00101	CcSEcCtD
Lisinopril—Somnolence—Niacin—atherosclerosis	9.53e-05	0.00101	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	9.48e-05	0.00292	CbGpPWpGaD
Lisinopril—Paraesthesia—Pravastatin—atherosclerosis	9.47e-05	0.001	CcSEcCtD
Lisinopril—Dyspepsia—Niacin—atherosclerosis	9.43e-05	0.000996	CcSEcCtD
Lisinopril—Dyspnoea—Pravastatin—atherosclerosis	9.41e-05	0.000994	CcSEcCtD
Lisinopril—Decreased appetite—Niacin—atherosclerosis	9.31e-05	0.000984	CcSEcCtD
Lisinopril—Dyspepsia—Pravastatin—atherosclerosis	9.29e-05	0.000981	CcSEcCtD
Lisinopril—Rash—Rosuvastatin—atherosclerosis	9.28e-05	0.000981	CcSEcCtD
Lisinopril—Dermatitis—Rosuvastatin—atherosclerosis	9.27e-05	0.00098	CcSEcCtD
Lisinopril—Urticaria—Simvastatin—atherosclerosis	9.27e-05	0.000979	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Niacin—atherosclerosis	9.25e-05	0.000977	CcSEcCtD
Lisinopril—Abdominal pain—Simvastatin—atherosclerosis	9.22e-05	0.000974	CcSEcCtD
Lisinopril—Body temperature increased—Simvastatin—atherosclerosis	9.22e-05	0.000974	CcSEcCtD
Lisinopril—Headache—Rosuvastatin—atherosclerosis	9.22e-05	0.000974	CcSEcCtD
Lisinopril—Hypersensitivity—Lovastatin—atherosclerosis	9.19e-05	0.000971	CcSEcCtD
Lisinopril—Decreased appetite—Pravastatin—atherosclerosis	9.17e-05	0.000969	CcSEcCtD
Lisinopril—Pain—Niacin—atherosclerosis	9.16e-05	0.000968	CcSEcCtD
Lisinopril—Fatigue—Pravastatin—atherosclerosis	9.1e-05	0.000961	CcSEcCtD
Lisinopril—Pain—Pravastatin—atherosclerosis	9.02e-05	0.000953	CcSEcCtD
Lisinopril—Constipation—Pravastatin—atherosclerosis	9.02e-05	0.000953	CcSEcCtD
Lisinopril—Hypersensitivity—Ezetimibe—atherosclerosis	9.02e-05	0.000952	CcSEcCtD
Lisinopril—Asthenia—Lovastatin—atherosclerosis	8.95e-05	0.000946	CcSEcCtD
Lisinopril—Pruritus—Lovastatin—atherosclerosis	8.83e-05	0.000932	CcSEcCtD
Lisinopril—Asthenia—Ezetimibe—atherosclerosis	8.78e-05	0.000927	CcSEcCtD
Lisinopril—Gastrointestinal pain—Niacin—atherosclerosis	8.76e-05	0.000926	CcSEcCtD
Lisinopril—Nausea—Rosuvastatin—atherosclerosis	8.74e-05	0.000924	CcSEcCtD
Lisinopril—Feeling abnormal—Pravastatin—atherosclerosis	8.69e-05	0.000918	CcSEcCtD
Lisinopril—Pruritus—Ezetimibe—atherosclerosis	8.66e-05	0.000915	CcSEcCtD
Lisinopril—Gastrointestinal pain—Pravastatin—atherosclerosis	8.63e-05	0.000911	CcSEcCtD
Lisinopril—Hypersensitivity—Simvastatin—atherosclerosis	8.6e-05	0.000908	CcSEcCtD
Lisinopril—Diarrhoea—Lovastatin—atherosclerosis	8.54e-05	0.000902	CcSEcCtD
Lisinopril—Urticaria—Niacin—atherosclerosis	8.51e-05	0.000899	CcSEcCtD
Lisinopril—Body temperature increased—Niacin—atherosclerosis	8.47e-05	0.000895	CcSEcCtD
Lisinopril—Abdominal pain—Niacin—atherosclerosis	8.47e-05	0.000895	CcSEcCtD
Lisinopril—Urticaria—Pravastatin—atherosclerosis	8.38e-05	0.000885	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—MMP1—atherosclerosis	8.38e-05	0.00258	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—HSPD1—atherosclerosis	8.38e-05	0.00258	CbGpPWpGaD
Lisinopril—Asthenia—Simvastatin—atherosclerosis	8.37e-05	0.000884	CcSEcCtD
Lisinopril—Diarrhoea—Ezetimibe—atherosclerosis	8.37e-05	0.000884	CcSEcCtD
Lisinopril—Body temperature increased—Pravastatin—atherosclerosis	8.34e-05	0.000881	CcSEcCtD
Lisinopril—Abdominal pain—Pravastatin—atherosclerosis	8.34e-05	0.000881	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—AGT—atherosclerosis	8.27e-05	0.00254	CbGpPWpGaD
Lisinopril—Pruritus—Simvastatin—atherosclerosis	8.26e-05	0.000872	CcSEcCtD
Lisinopril—Dizziness—Lovastatin—atherosclerosis	8.25e-05	0.000872	CcSEcCtD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	8.24e-05	0.00253	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—LEP—atherosclerosis	8.11e-05	0.00249	CbGpPWpGaD
Lisinopril—Dizziness—Ezetimibe—atherosclerosis	8.09e-05	0.000855	CcSEcCtD
Lisinopril—Diarrhoea—Simvastatin—atherosclerosis	7.98e-05	0.000843	CcSEcCtD
Lisinopril—Vomiting—Lovastatin—atherosclerosis	7.93e-05	0.000838	CcSEcCtD
Lisinopril—Hypersensitivity—Niacin—atherosclerosis	7.89e-05	0.000834	CcSEcCtD
Lisinopril—Rash—Lovastatin—atherosclerosis	7.87e-05	0.000831	CcSEcCtD
Lisinopril—Dermatitis—Lovastatin—atherosclerosis	7.86e-05	0.00083	CcSEcCtD
Lisinopril—Headache—Lovastatin—atherosclerosis	7.82e-05	0.000826	CcSEcCtD
Lisinopril—Vomiting—Ezetimibe—atherosclerosis	7.78e-05	0.000822	CcSEcCtD
Lisinopril—Hypersensitivity—Pravastatin—atherosclerosis	7.77e-05	0.000821	CcSEcCtD
Lisinopril—Dizziness—Simvastatin—atherosclerosis	7.72e-05	0.000815	CcSEcCtD
Lisinopril—Rash—Ezetimibe—atherosclerosis	7.72e-05	0.000815	CcSEcCtD
Lisinopril—Dermatitis—Ezetimibe—atherosclerosis	7.71e-05	0.000814	CcSEcCtD
Lisinopril—Asthenia—Niacin—atherosclerosis	7.69e-05	0.000812	CcSEcCtD
Lisinopril—Headache—Ezetimibe—atherosclerosis	7.67e-05	0.00081	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—F2—atherosclerosis	7.64e-05	0.00235	CbGpPWpGaD
Lisinopril—Pruritus—Niacin—atherosclerosis	7.58e-05	0.000801	CcSEcCtD
Lisinopril—Asthenia—Pravastatin—atherosclerosis	7.57e-05	0.0008	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	7.49e-05	0.0023	CbGpPWpGaD
Lisinopril—Pruritus—Pravastatin—atherosclerosis	7.46e-05	0.000788	CcSEcCtD
Lisinopril—Vomiting—Simvastatin—atherosclerosis	7.42e-05	0.000784	CcSEcCtD
Lisinopril—Nausea—Lovastatin—atherosclerosis	7.41e-05	0.000783	CcSEcCtD
Lisinopril—ABCB1—ABC-family proteins mediated transport—APOA1—atherosclerosis	7.38e-05	0.00227	CbGpPWpGaD
Lisinopril—Rash—Simvastatin—atherosclerosis	7.36e-05	0.000777	CcSEcCtD
Lisinopril—Dermatitis—Simvastatin—atherosclerosis	7.35e-05	0.000777	CcSEcCtD
Lisinopril—Diarrhoea—Niacin—atherosclerosis	7.33e-05	0.000774	CcSEcCtD
Lisinopril—Headache—Simvastatin—atherosclerosis	7.31e-05	0.000772	CcSEcCtD
Lisinopril—Nausea—Ezetimibe—atherosclerosis	7.27e-05	0.000768	CcSEcCtD
Lisinopril—Diarrhoea—Pravastatin—atherosclerosis	7.22e-05	0.000763	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL17A—atherosclerosis	7.12e-05	0.00219	CbGpPWpGaD
Lisinopril—Dizziness—Niacin—atherosclerosis	7.09e-05	0.000749	CcSEcCtD
Lisinopril—Dizziness—Pravastatin—atherosclerosis	6.98e-05	0.000737	CcSEcCtD
Lisinopril—Nausea—Simvastatin—atherosclerosis	6.93e-05	0.000732	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—INS—atherosclerosis	6.92e-05	0.00213	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CCL2—atherosclerosis	6.81e-05	0.0021	CbGpPWpGaD
Lisinopril—Vomiting—Niacin—atherosclerosis	6.81e-05	0.00072	CcSEcCtD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	6.81e-05	0.00209	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	6.79e-05	0.00209	CbGpPWpGaD
Lisinopril—Rash—Niacin—atherosclerosis	6.76e-05	0.000714	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—F7—atherosclerosis	6.75e-05	0.00208	CbGpPWpGaD
Lisinopril—Dermatitis—Niacin—atherosclerosis	6.75e-05	0.000713	CcSEcCtD
Lisinopril—Headache—Niacin—atherosclerosis	6.71e-05	0.000709	CcSEcCtD
Lisinopril—Vomiting—Pravastatin—atherosclerosis	6.71e-05	0.000709	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—IGF1—atherosclerosis	6.7e-05	0.00206	CbGpPWpGaD
Lisinopril—Rash—Pravastatin—atherosclerosis	6.65e-05	0.000703	CcSEcCtD
Lisinopril—Dermatitis—Pravastatin—atherosclerosis	6.65e-05	0.000702	CcSEcCtD
Lisinopril—Headache—Pravastatin—atherosclerosis	6.61e-05	0.000698	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—MMP2—atherosclerosis	6.48e-05	0.00199	CbGpPWpGaD
Lisinopril—Nausea—Niacin—atherosclerosis	6.36e-05	0.000672	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CD40—atherosclerosis	6.31e-05	0.00194	CbGpPWpGaD
Lisinopril—Nausea—Pravastatin—atherosclerosis	6.27e-05	0.000662	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	6.11e-05	0.00188	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—GHRL—atherosclerosis	6.02e-05	0.00185	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	6e-05	0.00184	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	5.88e-05	0.00181	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—AGTR1—atherosclerosis	5.77e-05	0.00178	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	5.65e-05	0.00174	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CXCL8—atherosclerosis	5.39e-05	0.00166	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PLAUR—atherosclerosis	5.24e-05	0.00161	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PLG—atherosclerosis	5.12e-05	0.00157	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL10—atherosclerosis	4.84e-05	0.00149	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CD40LG—atherosclerosis	4.84e-05	0.00149	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGF2—atherosclerosis	4.66e-05	0.00143	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—LEP—atherosclerosis	4.6e-05	0.00141	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—FASLG—atherosclerosis	4.5e-05	0.00138	CbGpPWpGaD
Lisinopril—Nateglinide—ALB—atherosclerosis	4.38e-05	0.0151	CrCbGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CETP—atherosclerosis	4.35e-05	0.00134	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	4.28e-05	0.00132	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	4.08e-05	0.00126	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.84e-05	0.00118	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MMP1—atherosclerosis	3.74e-05	0.00115	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—AGT—atherosclerosis	3.7e-05	0.00114	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—LEP—atherosclerosis	3.62e-05	0.00111	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	3.61e-05	0.00111	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	3.56e-05	0.00109	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—F2—atherosclerosis	3.41e-05	0.00105	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	3.34e-05	0.00103	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PLG—atherosclerosis	3.26e-05	0.001	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	3.2e-05	0.000986	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	3.09e-05	0.000951	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—INS—atherosclerosis	3.09e-05	0.000951	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CCL2—atherosclerosis	3.04e-05	0.000936	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.01e-05	0.000926	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGF1—atherosclerosis	2.99e-05	0.00092	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MMP2—atherosclerosis	2.9e-05	0.000891	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.88e-05	0.000887	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IFNG—atherosclerosis	2.85e-05	0.000875	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	2.65e-05	0.000814	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL1B—atherosclerosis	2.54e-05	0.000781	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	2.53e-05	0.000779	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	2.49e-05	0.000766	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	2.48e-05	0.000763	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.43e-05	0.000748	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CXCL8—atherosclerosis	2.41e-05	0.00074	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	2.3e-05	0.000706	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.28e-05	0.000702	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	2.22e-05	0.000683	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	2.15e-05	0.000661	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	2.07e-05	0.000635	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	1.99e-05	0.000611	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	1.97e-05	0.000607	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	1.88e-05	0.000577	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TNF—atherosclerosis	1.84e-05	0.000567	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LDLRAP1—atherosclerosis	1.84e-05	0.000566	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.81e-05	0.000556	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLTP—atherosclerosis	1.73e-05	0.000533	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	1.62e-05	0.000499	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	1.58e-05	0.000487	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LTA4H—atherosclerosis	1.5e-05	0.000462	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCG8—atherosclerosis	1.5e-05	0.000462	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	1.47e-05	0.000453	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	1.35e-05	0.000414	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.3e-05	0.000399	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCG1—atherosclerosis	1.19e-05	0.000365	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.17e-05	0.000359	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.15e-05	0.000353	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FABP4—atherosclerosis	1.12e-05	0.000343	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LCAT—atherosclerosis	1.12e-05	0.000343	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.1e-05	0.000339	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOA4—atherosclerosis	1.1e-05	0.000337	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.08e-05	0.000331	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.06e-05	0.000326	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.02e-05	0.000313	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1e-05	0.000309	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP27A1—atherosclerosis	9.94e-06	0.000306	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	9.75e-06	0.0003	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	9.73e-06	0.000299	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOA2—atherosclerosis	9.43e-06	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLA2G2A—atherosclerosis	9.43e-06	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALOX5AP—atherosclerosis	9.43e-06	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALOX15—atherosclerosis	9.43e-06	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCG5—atherosclerosis	9.31e-06	0.000286	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	9.09e-06	0.00028	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPA—atherosclerosis	8.99e-06	0.000277	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—BGN—atherosclerosis	8.71e-06	0.000268	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOA5—atherosclerosis	8.62e-06	0.000265	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLA2G1B—atherosclerosis	8.3e-06	0.000255	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	8.22e-06	0.000253	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALOX5—atherosclerosis	8.01e-06	0.000247	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.71e-06	0.000237	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NAMPT—atherosclerosis	7.19e-06	0.000221	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LIPC—atherosclerosis	7.14e-06	0.00022	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOC3—atherosclerosis	7.1e-06	0.000218	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LDLR—atherosclerosis	7.06e-06	0.000217	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CETP—atherosclerosis	6.89e-06	0.000212	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.77e-06	0.000208	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SCARB1—atherosclerosis	6.6e-06	0.000203	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMGCR—atherosclerosis	6.23e-06	0.000192	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	6.11e-06	0.000188	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCA1—atherosclerosis	5.56e-06	0.000171	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMOX1—atherosclerosis	4.77e-06	0.000147	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOB—atherosclerosis	4.57e-06	0.00014	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTM1—atherosclerosis	4.44e-06	0.000137	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPL—atherosclerosis	4.36e-06	0.000134	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPX1—atherosclerosis	4.25e-06	0.000131	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CD36—atherosclerosis	4.14e-06	0.000127	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTHFR—atherosclerosis	3.93e-06	0.000121	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARA—atherosclerosis	3.85e-06	0.000118	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AGT—atherosclerosis	3.73e-06	0.000115	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOE—atherosclerosis	3.65e-06	0.000112	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CAV1—atherosclerosis	3.62e-06	0.000111	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOA1—atherosclerosis	3.61e-06	0.000111	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.3e-06	0.000101	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARG—atherosclerosis	3.18e-06	9.79e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—INS—atherosclerosis	3.12e-06	9.6e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—atherosclerosis	2.86e-06	8.8e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NOS3—atherosclerosis	2.74e-06	8.42e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—atherosclerosis	2.5e-06	7.7e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKT1—atherosclerosis	1.26e-06	3.87e-05	CbGpPWpGaD
